NVO — NOVO NORDISK A S
—
NYSE ·
Health Care ·
Pharmaceuticals ·
CIK 353278 ·
Last close
$47.42
Market Cap
$158.95B
52W High
$47.79
52W Low
$34.62
ADV30
13,187,978
Next earnings
2026-08-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 96,823,000,000 | 83,225,000,000 | 59,618,000,000 | 48,557,000,000 | 559,221,000,000 | 21,127,000,000 | 356,156,000,000 |
| Dec 2025 | 79,144,000,000 | 63,996,000,000 | 31,736,000,000 | 26,891,000,000 | 542,902,000,000 | 26,464,000,000 | 348,855,000,000 |
| Sep 2025 | 74,976,000,000 | 57,072,000,000 | 23,682,000,000 | 20,006,000,000 | 512,288,000,000 | 32,084,000,000 | 342,392,000,000 |
| Jun 2025 | 76,857,000,000 | 64,011,000,000 | 33,449,000,000 | 26,503,000,000 | 482,153,000,000 | 18,435,000,000 | 314,087,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$118,456,000,000
Investing CF
$-84,891,000,000
Financing CF
$-50,459,000,000
CapEx
$-87,566,000,000
Dividends Paid
$-51,801,000,000
Buybacks
$-2,400,000,000
EPS Diluted TTM
$27.41
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$206,420,000,000
Inventory
$51,352,000,000
Receivables
$100,268,000,000
ST Investments
$499,000,000
EBIT TTM
$159,852,000,000
Pretax Income TTM
$155,679,000,000
Interest Exp TTM
$4,051,000,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$327,799,996,416
EBITDA
$173,876,002,816
Free Cash Flow
$-12,039,249,920
Enterprise Value
$335,421,407,232
Total Cash
$21,625,999,360
Total Debt
$146,381,996,032
Shares Out
3,351,983,520
Trailing EPS
$4.20
Book Value
$7.01
ROE
71.4%
ROA
19.2%
Div Yield
3.80%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 309,064,000,000 | 127,658,000,000 | 102,434,000,000 | 542,902,000,000 | 348,855,000,000 | — | 119,102,000,000 |
| Dec 2024 | 290,403,000,000 | 128,339,000,000 | 100,988,000,000 | 465,630,000,000 | 322,144,000,000 | — | 120,968,000,000 |
| Dec 2023 | 232,261,000,000 | 102,574,000,000 | 83,683,000,000 | 314,486,000,000 | 207,925,000,000 | — | 108,908,000,000 |
| Dec 2022 | 176,954,000,000 | 74,809,000,000 | 55,525,000,000 | 241,257,000,000 | 157,771,000,000 | — | 78,887,000,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$3.30
Max Pain — expiry 2026-06-26
max pain strike: $44.00 · spot: $47.53 · call oi: 26,897 · put oi: 12,778
Expected Move to 2026-06-26:
±$1.30
(2.74%) —
implied range
$46.23 –
$48.83
· ATM straddle on $47.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | $157.69B | $90.53 | — |
| NONOF | NOVO NORDISK A S | $154.49B | $46.09 | — |
| PFE | PFIZER INC | $140.89B | $24.72 | — |
| VRTX | VERTEX PHARMACEUTICALS INC / MA | $118.89B | $468.42 | — |
| BMY | BRISTOL MYERS SQUIBB CO | $113.40B | $55.53 | — |
News headlines (Yahoo Finance, 1h cache)
Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays’ Target Increase?
2026-06-24 13:27 · Yahoo
Is Novo Nordisk A/S (NVO) Strengthening Its Weight-Loss Leadership With Oral Wegovy Launch?
2026-06-24 13:27 · Yahoo
LLY or PFE: Which Drugmaker Offers the Stronger Growth Story?
2026-06-24 12:59 · Yahoo
Recent pharma exec shake-ups signal strategic shifts
2026-06-24 09:00 · Yahoo
VKTX Stock Clocks Best Day In Nearly 3 Months On Obesity Pipeline Optimism, Buyout Speculation
2026-06-23 23:46 · Yahoo
Novo Nordisk A/S (NVO) Primary Owner to Open Obesity Drug Incubators Across Europe
2026-06-23 19:53 · Yahoo
Forget Novo Nordisk. Pfizer’s Obesity Pipeline Is Coming, and It Pays You 6.8% While You Wait
2026-06-23 17:55 · Yahoo
NVO Gains as Foundation Unveils EUR 60M Cardiometabolic Research Push
2026-06-23 15:07 · Yahoo
Hims & Hers Health (HIMS) Expands GLP 1 Offerings With Novo Nordisk Deal And Eucalyptus Buy
2026-06-23 09:06 · Yahoo
2 Underrated Weight Loss Stocks to Buy and Hold
2026-06-23 07:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.